Incannex Healthcare Limited (IXHL)

USD 0.13

(-0.15%)

Gross Profit Summary of Incannex Healthcare Limited

  • Incannex Healthcare Limited's latest annual gross profit in 2024 was 12 Thousand USD , down 0.0% from previous year.
  • Incannex Healthcare Limited's latest quarterly gross profit in 2024 Q3 was -17 Thousand USD , down 0.0% from previous quarter.
  • Incannex Healthcare Limited reported a annual gross profit of 1.01 Million AUD in annual gross profit 2023, up 30.65% from previous year.
  • Incannex Healthcare Limited reported a annual gross profit of 776.04 Thousand AUD in annual gross profit 2022, up 4.79% from previous year.
  • Incannex Healthcare Limited reported a quarterly gross profit of -17 Thousand USD for 2024 Q3, down 0.0% from previous quarter.
  • Incannex Healthcare Limited reported a quarterly gross profit of - USD for 2024 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Incannex Healthcare Limited (2024 - 2007)

Historical Annual Gross Profit of Incannex Healthcare Limited (2024 - 2007)

Year Gross Profit Gross Profit Growth
2024 12 Thousand USD 0.0%
2023 1.01 Million AUD 30.65%
2022 776.04 Thousand AUD 4.79%
2021 740.53 Thousand AUD 597.4%
2020 106.18 Thousand AUD -82.19%
2019 596.25 Thousand AUD 22.15%
2018 488.15 Thousand AUD 308.21%
2017 -234.45 Thousand AUD 0.0%
2016 - AUD 0.0%
2015 - AUD 0.0%
2014 - AUD -100.0%
2013 35.73 Thousand AUD -46.12%
2012 66.31 Thousand AUD 0.0%
2011 - AUD -100.0%
2010 26.18 Thousand AUD 0.0%
2009 - AUD 0.0%
2008 - AUD 0.0%
2007 - AUD 0.0%

Peer Gross Profit Comparison of Incannex Healthcare Limited

Name Gross Profit Gross Profit Difference
Esperion Therapeutics, Inc. 73.06 Million USD 99.984%
Theratechnologies Inc. 62.12 Million USD 99.981%
Safety Shot Inc -74.45 Thousand USD 116.117%
Cosmos Health Inc. 4.34 Million USD 99.724%
Cronos Group Inc. 6.99 Million USD 99.828%
Ironwood Pharmaceuticals, Inc. 441.16 Million USD 99.997%
Kala Pharmaceuticals, Inc. -303 Thousand USD 103.96%
Organogenesis Holdings Inc. 309.79 Million USD 99.996%
Universe Pharmaceuticals INC 10.07 Million USD 99.881%
ProPhase Labs, Inc. 16.23 Million USD 99.926%
Sonoma Pharmaceuticals, Inc. 4.74 Million USD 99.747%
Dynavax Technologies Corporation 182.11 Million USD 99.993%
Radius Health, Inc. 307.71 Million USD 99.996%
China SXT Pharmaceuticals, Inc. 553.97 Thousand USD 97.834%
Alvotech -69.42 Million USD 100.017%
Sunshine Biopharma, Inc. 8.33 Million USD 99.856%
Alpha Teknova, Inc. 10.29 Million USD 99.883%
Intra-Cellular Therapies, Inc. 430.62 Million USD 99.997%
SCYNEXIS, Inc. 124.51 Million USD 99.99%
Harrow Health, Inc. 90.55 Million USD 99.987%
Biofrontera Inc. 16.62 Million USD 99.928%
DURECT Corporation 6.83 Million USD 99.824%
Supernus Pharmaceuticals, Inc. 523.74 Million USD 99.998%
ANI Pharmaceuticals, Inc. 305.3 Million USD 99.996%
OptiNose, Inc. 62.35 Million USD 99.981%
RedHill Biopharma Ltd. 3.05 Million USD 99.607%
Aquestive Therapeutics, Inc. 29.75 Million USD 99.96%
Cumberland Pharmaceuticals Inc. 33.48 Million USD 99.964%
SIGA Technologies, Inc. 122.09 Million USD 99.99%
Lifecore Biomedical, Inc. 41.85 Million USD 99.971%
Shineco, Inc. 882.16 Thousand USD 98.64%
Phibro Animal Health Corporation 312.48 Million USD 99.996%
Procaps Group S.A. 239.56 Million USD 99.995%
TherapeuticsMD, Inc. 1.3 Million USD 99.078%
Regencell Bioscience Holdings Limited -745.58 Thousand USD 101.609%
Viatris Inc. 6.43 Billion USD 100.0%
Sunshine Biopharma, Inc. 8.33 Million USD 99.856%
Rockwell Medical, Inc. 8.7 Million USD 99.862%
Aytu BioPharma, Inc. 54.58 Million USD 99.978%
Tilray Brands, Inc. 223.35 Million USD 99.995%
Collegium Pharmaceutical, Inc. 326.16 Million USD 99.996%
PetIQ, Inc. 252.74 Million USD 99.995%
Silver Spike Investment Corp. 8.1 Million USD 99.852%
Neurocrine Biosciences, Inc. 1.84 Billion USD 99.999%
Journey Medical Corporation 52.52 Million USD 99.977%
Alimera Sciences, Inc. 61.17 Million USD 99.98%
Petros Pharmaceuticals, Inc. 4.19 Million USD 99.714%
Assertio Holdings, Inc. 125.04 Million USD 99.99%
Shuttle Pharmaceuticals Holdings, Inc. -6811.00 USD 276.186%
Embecta Corp. 749.9 Million USD 99.998%
Cyclo Therapeutics, Inc. -2.41 Million USD 100.498%
Procaps Group, S.A. 239.56 Million USD 99.995%
PainReform Ltd. -15 Thousand USD 180.0%
Avadel Pharmaceuticals plc 27.11 Million USD 99.956%
Hempacco Co., Inc. -1.21 Million USD 100.987%
Talphera, Inc. -4.89 Million USD 100.245%
Pacira BioSciences, Inc. 490.3 Million USD 99.998%
Alvotech -69.42 Million USD 100.017%
Lantheus Holdings, Inc. 709.54 Million USD 99.998%
Kamada Ltd. 52.59 Million USD 99.977%
Indivior PLC 907 Million USD 99.999%
Currenc Group, Inc. 17.35 Million USD 99.931%
Evoke Pharma, Inc. 4.97 Million USD 99.759%
Flora Growth Corp. 17.73 Million USD 99.932%
Cyclo Therapeutics, Inc. -2.41 Million USD 100.498%
Evolus, Inc. 140.52 Million USD 99.991%
HUTCHMED (China) Limited 453.55 Million USD 99.997%
Amphastar Pharmaceuticals, Inc. 343.96 Million USD 99.997%
Akanda Corp. 111.44 Thousand USD 89.233%